Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBPP) Short-Term Debt issuances (2023 - 2025)

Regen BioPharma (RGBPP) has disclosed Short-Term Debt issuances for 4 consecutive years, with -$58836.0 as the latest value for Q4 2025.

  • On a quarterly basis, Short-Term Debt issuances changed N/A to -$58836.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $65157.0, a N/A change, with the full-year FY2025 number at $50000.0, down 35.48% from a year prior.
  • Short-Term Debt issuances was -$58836.0 for Q4 2025 at Regen BioPharma, down from $117995.0 in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $117995.0 in Q3 2024 to a low of -$58836.0 in Q4 2025.
  • A 3-year average of $3731.4 and a median of -$15000.0 in 2024 define the central range for Short-Term Debt issuances.